GEN Exclusives

More »

GEN News Highlights

More »
Mar 8, 2007

Avax and Cancer Treatment Centers of America to Work on Personalized Vaccine for Ovarian Cancer

  • Cancer Treatment Centers of America reports that it plans to make a new cancer vaccine therapy for women with advanced-stage ovarian cancer by this summer. Avax Technologies will develop this treatment, which will use the patient's own tumor tissues.

    This patient-specific vaccine will be combined with chemotherapy delivered directly into the abdominal cavity. It will be offered to patients whose cancer have recurred after chemotherapy.

    Cancer Treatment Centers of America hopes to eventually make this form of vaccine available to treat other forms of cancer, including colorectal and lung cancer patients, as well as patients with malignant melanomas.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Genetics and Intelligence

Do you believe research on the genetics of intelligence can improve education?

More »